GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Holdings Lifted by WD Rutherford LLC

WD Rutherford LLC lifted its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 61.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 6,085 shares of the company’s stock after acquiring an additional 2,305 shares during the period. WD Rutherford LLC’s holdings in GE HealthCare Technologies were worth $454,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in GEHC. First Command Advisory Services Inc. grew its position in GE HealthCare Technologies by 36,900.0% during the third quarter. First Command Advisory Services Inc. now owns 370 shares of the company’s stock valued at $25,000 after purchasing an additional 369 shares in the last quarter. Fortitude Family Office LLC purchased a new position in GE HealthCare Technologies during the fourth quarter valued at approximately $29,000. Legacy Financial Group LLC purchased a new position in GE HealthCare Technologies during the third quarter valued at approximately $26,000. Turtle Creek Wealth Advisors LLC purchased a new position in GE HealthCare Technologies during the fourth quarter valued at approximately $30,000. Finally, OFI Invest Asset Management purchased a new position in GE HealthCare Technologies during the third quarter valued at approximately $26,000. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Up 0.3 %

Shares of GE HealthCare Technologies stock opened at $86.24 on Friday. The firm has a market capitalization of $39.35 billion, a PE ratio of 28.56, a price-to-earnings-growth ratio of 2.99 and a beta of 0.94. The company has a debt-to-equity ratio of 1.18, a current ratio of 1.05 and a quick ratio of 0.83. The company’s fifty day moving average price is $88.92 and its two-hundred day moving average price is $78.45. GE HealthCare Technologies Inc. has a 52-week low of $62.35 and a 52-week high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Tuesday, February 6th. The company reported $1.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.07 by $0.11. The firm had revenue of $5.20 billion for the quarter, compared to analyst estimates of $5.09 billion. GE HealthCare Technologies had a net margin of 8.02% and a return on equity of 25.58%. The business’s revenue for the quarter was up 5.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.31 EPS. On average, analysts expect that GE HealthCare Technologies Inc. will post 4.3 EPS for the current year.

GE HealthCare Technologies Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date is Thursday, April 18th. GE HealthCare Technologies’s dividend payout ratio (DPR) is presently 3.97%.

Analyst Ratings Changes

A number of research firms have issued reports on GEHC. Argus lifted their target price on shares of GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Evercore ISI lifted their target price on shares of GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. Morgan Stanley lifted their target price on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the company an “equal weight” rating in a research note on Monday, February 12th. HSBC began coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They issued a “buy” rating and a $100.00 target price for the company. Finally, Citigroup lifted their target price on shares of GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Four investment analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $95.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.